Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci
- PMID: 25837820
- PMCID: PMC4491026
- DOI: 10.1158/1055-9965.EPI-14-0317
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci
Abstract
Background: Genome-wide association studies have identified multiple genetic variants associated with prostate cancer risk which explain a substantial proportion of familial relative risk. These variants can be used to stratify individuals by their risk of prostate cancer.
Methods: We genotyped 25 prostate cancer susceptibility loci in 40,414 individuals and derived a polygenic risk score (PRS). We estimated empirical odds ratios (OR) for prostate cancer associated with different risk strata defined by PRS and derived age-specific absolute risks of developing prostate cancer by PRS stratum and family history.
Results: The prostate cancer risk for men in the top 1% of the PRS distribution was 30.6 (95% CI, 16.4-57.3) fold compared with men in the bottom 1%, and 4.2 (95% CI, 3.2-5.5) fold compared with the median risk. The absolute risk of prostate cancer by age of 85 years was 65.8% for a man with family history in the top 1% of the PRS distribution, compared with 3.7% for a man in the bottom 1%. The PRS was only weakly correlated with serum PSA level (correlation = 0.09).
Conclusions: Risk profiling can identify men at substantially increased or reduced risk of prostate cancer. The effect size, measured by OR per unit PRS, was higher in men at younger ages and in men with family history of prostate cancer. Incorporating additional newly identified loci into a PRS should improve the predictive value of risk profiles.
Impact: We demonstrate that the risk profiling based on SNPs can identify men at substantially increased or reduced risk that could have useful implications for targeted prevention and screening programs.
©2015 American Association for Cancer Research.
Conflict of interest statement
Figures
Comment in
-
Risk Analysis of Prostate Cancer in PRACTICAL Consortium-Letter.Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):222. doi: 10.1158/1055-9965.EPI-15-0904. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26762807 No abstract available.
-
Risk Analysis of Prostate Cancer in PRACTICAL Consortium--Response.Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):223. doi: 10.1158/1055-9965.EPI-15-1005. Cancer Epidemiol Biomarkers Prev. 2016. PMID: 26762808 Free PMC article. No abstract available.
References
-
- Amin Al Olama A, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet. 2009;41:1058–1060. - PubMed
-
- Eeles RA, Kote-Jarai Z, Giles GG, Amin Al Olama A, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40:316–321. - PubMed
-
- Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38:652–658. - PubMed
Publication types
MeSH terms
Grants and funding
- 17528/CRUK_/Cancer Research UK/United Kingdom
- 1U19CA148537-01/CA/NCI NIH HHS/United States
- A10118/CRUK_/Cancer Research UK/United Kingdom
- A10692/CRUK_/Cancer Research UK/United Kingdom
- C5047/A10692/CRUK_/Cancer Research UK/United Kingdom
- P30 CA076292/CA/NCI NIH HHS/United States
- U19 CA148537/CA/NCI NIH HHS/United States
- 15007/CRUK_/Cancer Research UK/United Kingdom
- 16563/CRUK_/Cancer Research UK/United Kingdom
- 10118/CRUK_/Cancer Research UK/United Kingdom
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- P30 CA042014/CA/NCI NIH HHS/United States
- 11174/CRUK_/Cancer Research UK/United Kingdom
- P30 CA015704/CA/NCI NIH HHS/United States
- 10124/CRUK_/Cancer Research UK/United Kingdom
- R24 AI106039/AI/NIAID NIH HHS/United States
- 16561/CRUK_/Cancer Research UK/United Kingdom
- 13065/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous